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SUMMARY – Th e aim of this study was to investigate the controversial infl uence of anthropom-
etry on clinical severity and prognosis of acute ST-elevation myocardial infarction (STEMI). We 
prospectively analyzed 250 patients with acute STEMI treated with primary percutaneous coronary 
intervention (September 2011 – September 2012). Th ey were grouped according to the following 
anthropometric parameters: body mass index (BMI) (<25.0, 25.0-29.9, ≥30.0 kg/m²), waist circumfer-
ence (WC) (<102/88, ≥102/88 cm), waist-to-hip ratio (WHR) (<0.90/0.85, ≥0.90/0.85) and waist-
to-height ratio (WHtR) (<53/49, 53/49-62/57, ≥63/58). Th e groups were analyzed by baseline, as well 
as severity (clinical, laboratory, echocardiography, coronary angiography, in-hospital complications) 
and prognostic parameters (major adverse cardiovascular events and sick leave duration during 
12-month follow up). Patients with BMI <25.0 kg/m2 had the highest rates of dyspnea and those with 
BMI ≥30.0 kg/m² had the longest hospitalization and widest stents; patients with WHR ≥0.90/0.85 
had higher rates of signifi cantly stenosed proximal/middle coronary segments, while those with 
WHtR ≥63/58 had the highest rates of heart failure and total in-hospital complications (p<0.05). 
BMI <25.0 kg/m2 increased (odds ratio (OR) 2.00, confi dence interval (CI) [1.09-3.68], p=0.026) and 
BMI 25.0-29.9 kg/m2 reduced (OR 0.52, CI [0.30-0.91], p=0.022) the risk of dyspnea; WHR 
≥0.90/0.85 increased the risk of signifi cant proximal/middle coronary segment stenosis (OR 3.34, CI 
[1.13-9.86], p=0.029) and WHtR ≥63/58 the risk of heart failure (OR 2.05, CI [1.13-3.71], p=0.017) 
and total in-hospital complications (OR 1.94, CI [1.13-3.33], p=0.017) (p<0.05). In conclusion, 
WHR and WHtR are better anthropometric parameters than BMI in predicting acute STEMI sever-
ity, while WC has no infl uence on it. Anthropometry has no infl uence on prognosis.
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Introduction
Overweight and obesity are one of the major public 
health problems. Worldwide, at least 1.4 billion adults 
are overweight, i.e. over 200 million men and nearly 
300 million women are obese1. Obesity prevalence in 
Europe has reached epidemic proportions (up to 
28.3% of men and 36.5% of women) with higher prev-
alence rates in Central, Eastern, and Southern Europe 
than those in Western and Northern Europe2. Obesity 
is an independent risk factor for the development of 
cardiovascular disease (CVD), including coronary ar-
tery disease (CAD) and heart failure. It is frequently 
associated with other CVD risk factors such as arterial 
hypertension, diabetes mellitus type 2, atherogenic 
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dyslipidemia, as well as with an increased risk of all-
cause morbidity and mortality3. Measurement of body 
mass index (BMI), waist circumference (WC), waist-
to-hip ratio (WHR) and waist-to-height ratio 
(WHtR) is a primary method for diagnosing obesity. 
While BMI determines overall obesity, other anthro-
pometric parameters are related to central obesity 
where body fat is primarily located in the abdomen. 
Central obesity measures, especially WHtR, are stron-
ger predictors of CVD risk than BMI4,5. Central obe-
sity correlates with excessive visceral fat, which is di-
rectly associated with insulin resistance and compen-
satory hyperinsulinemia, dyslipidemia and infl amma-
tory states that synergistically lead to smooth muscle 
cell proliferation, calcium and cholesterol ester deposi-
tion in the artery, and fi nally to atherosclerotic vascular 
disease6. In subjects with acute myocardial infarction 
(MI), there is positive association of abdominal obesity 
and decreasing BMI with higher mortality. Th is has 
been called the ‘obesity paradox’. Th e possible explana-
tion could be that BMI does not adequately discrimi-
nate the diff erence between body fat (especially ab-
dominal) and lean muscle mass4.
Using the anthropometric parameters, the aims of 
this study were:
1. to evaluate the baseline data of patients with 
obesity and acute ST-elevation myocardial in-
farction (STEMI), and to compare the results 
with STEMI patients without obesity;
2. to evaluate the severity and prognosis of acute 
STEMI in patients with obesity, and to com-
pare the results with STEMI patients without 
obesity; and
3. to investigate the controversial infl uence of an-
thropometric parameters on clinical severity 
and prognosis of acute STEMI, as well as their 
unknown infl uence on the involvement of coro-
nary artery segments with signifi cant stenosis 
and sick leave duration (SLD).
Patients and Methods
Patient population
Th is prospective monocentric study was performed 
on 250 consecutive patients with acute STEMI. Th ey 
were treated with primary percutaneous coronary in-
tervention (PCI) at Department of Cardiology, Sestre 
milosrdnice University Hospital Center (September 
2011 – September 2012). Th e diagnosis was estab-
lished and primary PCI performed using the criteria 
of the European Society of Cardiology7,8. Th e inclu-
sion criteria were presenting within 12 h from the on-
set of symptoms (history of chest pain/discomfort 
lasting for 10-20 minutes or more, not responding 
fully to nitroglycerine), persistent ST-segment eleva-
tion on electrocardiography in at least two consecutive 
leads, or (presumed) new left bundle-branch block, 
and elevated cardiac laboratory biomarkers (cardiac 
troponin T (cTnT) and creatine kinase (CK)). Th e 
study was approved by the Ethics Committee of the 
Sestre milosrdnice University Hospital Center, Za-
greb, Croatia.
Data collection
After primary PCI, patients were grouped accord-
ing to anthropometric parameters as follows: BMI 
(<25.0, 25.0-29.9 and ≥30.0 kg/m² for normal weight, 
overweight and overall obesity, respectively), WC 
(<102/88 and ≥102/88 cm for normal weight and cen-
tral obesity in males/females, respectively), WHR 
(<0.90/0.85 and ≥0.90/0.85 for normal weight and 
central obesity in males/females, respectively) and 
WHtR (<53/49, 53/49-62/57 and ≥63/58 for normal 
weight, overweight and central obesity in males/fe-
males, respectively)4,9. Th e groups were analyzed by 
baseline, as well as severity and prognostic parameters 
of acute STEMI.
Baseline parameters
Baseline demographic and medical history param-
eters included gender, age, arterial hypertension, dys-
lipidemia (elevated triglycerides and/or low HDL-
cholesterol), hyperglycemia, smoking status, known 
family history of cardiovascular events (MI, cerebro-
vascular insult), previous MI, previous PCI and coro-
nary artery bypass grafting (CABG).
For the diagnosis of dyslipidemia, hypertension 
and hyperglycemia, we used the criteria published by 
the National Cholesterol Education Program – Adult 
Treatment Panel III group9, as follows:
1. hypertriglyceridemia: triglycerides ≥150 mg/dL 
(1.7 mmol/L), or on medication for elevated 
triglycerides;
2. low HDL-cholesterol: <40 mg/dL (1.04 mmol/
L) in males or <50 mg/dL (1.29 mmol/L) in 
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females, or on medication for low HDL-cho-
lesterol;
3. hypertension: blood pressure ≥130/85 mm Hg, 
or on medication for hypertension; and
4. hyperglycemia: fasting plasma glucose ≥100 
mg/dL (5.6 mmol/L), or on medication for hy-
perglycemia.
Severity parameters
Th e severity of acute STEMI was estimated by 
clinical presentation (angina pectoris, dyspnea, and 
length of hospitalization), in-hospital complications 
(arrhythmias, conduction disturbances, reperfusion ar-
rhythmias, heart failure, cardiogenic shock, cardiac ar-
rest, mechanical ventilation, reinfarction, repeated 
PCI, mortality, and total in-hospital complications), 
laboratory (maximal cTnT, CK), echocardiography 
(left ventricular ejection fraction, LVEF) and coronary 
angiography fi ndings.
Serum CK activity was measured by spectropho-
tometry (Olympus 680, Beckman Coulter Inc., Cali-
fornia, USA). Serum cTnT levels were measured by 
electrochemiluminescence (ECL) assay (Cobas e411, 
Roche Diagnostics, Sussex, UK). During hospital stay, 
echocardiography (Acuson Sequoia 512, Siemens, 
Munich, Germany) was performed in all patients ac-
cording to the clinical standards and current echocar-
diography guidelines10.
Coronary angiography was performed by applying 
a monoplane system (Axiom Artis, Siemens, Erlangen, 
Germany) by a common technique, as recommended 
in current guidelines8. Patients received 70 IE/kg un-
fractionated heparin, 300 mg aspirin, a loading dose of 
600 mg clopidogrel, and a GPIIb/IIIa inhibitor ac-
cording to judgment of interventional cardiologist. 
Coronary artery stenosis of more than 50% was con-
sidered clinically signifi cant. We analyzed the number 
of signifi cantly narrowed coronary arteries, and num-
ber, length and diameter of stents used. Additionally, 
for the fi rst time, we analyzed signifi cantly stenosed 
segments of coronary arteries. For that purpose, and 
according to the modifi ed American Heart Associa-
tion classifi cation11, coronary arteries were divided into 
16 segments. Segments were classifi ed in two groups, 
as follows:
1. proximal and middle coronary segments: seg-
ment 1 (right coronary artery (RCA), proxi-
mal), segment 2 (RCA, mid), segment 5 (main 
stem), segment 6 (left anterior descending cor-
onary artery (LAD), proximal), segment 7 
(LAD, mid), segment 9 (fi rst diagonal), seg-
ment 11 (left circumfl ex artery (LCX), proxi-
mal), segment 12 (obtuse marginal); and
2. distal coronary segments: segment 3 (RCA, dis-
tal), segment 4 (right posterior descendens), 
segment 8 (LAD, distal), segment 10 (second 
diagonal), segment 13 (LCX, distal), segment 
14 (LCX, posterolateral branch), segment 15 
(LCX, posterodescendens branch), segment 16 
(RCA, posterolateral branch).
Prognostic parameters
Th e prognosis of acute STEMI was estimated us-
ing major adverse cardiovascular events (MACE) pa-
rameters (reinfarction, coronary artery restenosis and/
or new stenosis, cardiac and non-cardiac rehospitaliza-
tion, cerebrovascular insult, urgent CABG, mortality, 
total MACE) during 12-month follow up. Data were 
collected by medical examination, checking medical 
documentation, or telephone contact with patients, 
family members or home physicians. In addition, dur-
ing the same follow up period, we collected data on 
SLD of working population.
Statistical analysis
Qualitative data were expressed as absolute num-
ber and percentage. We used c2-test with Yates correc-
tion for comparison and analysis. Quantitative data 
were expressed as median and corresponding inter-
quartile range. Diff erences between two groups were 
tested by Mann-Whitney U test. Diff erences among 
three groups were tested by nonparametric analysis of 
variance (Kruskal-Wallis ANOVA). Logistic regres-
sion analysis was used to investigate the relationship 
between one dependent and one or more independent 
variables that may infl uence or predict the value of the 
dependent variable. Th e limit of statistical signifi cance 
was set at p<0.05. Processing was done using the STA-
TISTICA 6.0 for Windows software.
Results
Among 250 patients, there were 72 (28.8%) pa-
tients with BMI ≥30.0 kg/m², 149 (59.6%) with WC 
≥102/88 cm, 222 (88.8%) with WHR ≥0.90/0.85 and 
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81 (32.4%) with WHtR ≥63/58. We recorded the fol-
lowing results:
1) BMIs ≥30.0 kg/m² had the highest rates of hy-
pertension and dyslipidemia, the longest hospitaliza-
tion and widest stents, while BMIs <25.0 kg/m2 had 
the highest rates of dyspnea (p<0.05). Other baseline 
and parameters of severity, as well as all prognostic pa-
rameters were without signifi cant diff erences (Tables 1 
and 2).
2) WCs ≥102/88 cm were more frequently record-
ed in males and were associated with higher rates of 
hypertension (p<0.05). Other baseline, as well as all 
severity and prognostic parameters were without sig-
nifi cant diff erences (Tables 1 and 2).
3) WHRs ≥0.90/0.85 were more frequently found 
in males and were associated with higher rates of dyslip-
idemia and signifi cantly stenosed proximal/middle cor-
onary artery segments (p<0.05). Other baseline and pa-
rameters of severity, as well as all prognostic parameters 
were without signifi cant diff erences (Tables 3 and 4).
4) WHtRs ≥63/58 were more frequently found in 
females and were associated with the highest rates of 
arterial hypertension, heart failure and total in-hospi-
tal complications (p<0.05). Other baseline and param-
eters of severity, as well as all prognostic parameters 
were without signifi cant diff erences (Tables 3 and 4).
5) BMI <25.0 kg/m2 increased (OR 2.00, CI 
[1.09-3.68], p=0.026) and BMI 25.0-29.9 kg/m2 re-
duced the risk of dyspnea (OR 0.52, CI [0.30-0.91], 
p=0.022); WHR ≥0.90/0.85 adjusted for gender in-
creased the risk of signifi cant proximal/middle coro-
nary segment stenosis (OR 3.34, CI [1.13-9.86], 
p=0.029), while WHtR ≥63/58 adjusted for hypergly-
cemia increased the risk of heart failure (OR 2.05, CI 
[1.13-3.71] p=0.017) and total in-hospital complica-
tions (OR 1.94, CI [1.13-3.33] p=0.017). Th e number 
of signifi cantly stenosed coronary arteries, adjusted for 
LVEF and distal coronary segment stenosis increased 
the risk of total MACE (OR 1.79, CI [1.17-2.77], 
p=0.008).
Discussion
Th e main objective of this study was to investigate 
the controversial infl uence of anthropometric param-
eters on clinical severity and prognosis of acute STE-
MI, as well as their unknown infl uence on the involve-
ment of coronary segments with signifi cant stenosis 
and SLD.
We found the measures of central obesity (WHR 
and WHtR) to be superior to BMI in predicting clini-
cal severity (signifi cant proximal/middle coronary seg-
ment stenosis, heart failure and total in-hospital com-
plications vs. dyspnea), while WC had no infl uence on 
it. Also, anthropometric parameters had no infl uence 
on prognosis. Finally, the number of signifi cantly ste-














Men, n (%) 37 (61.7) 88 (74.6) 52 (72.2) 0.191 87 (86.1) 90 (60.4) 0.000
Women, n (%) 23 (38.3) 30 (25.4) 20 (27.8) 0.191 14 (13.9) 59 (39.6) 0.000
Age (years) 64 (40-90) 62 (25-92) 61 (39-85) 0.201 60 (41-90) 63 (25-92) 0.080
Arterial hypertension, n (%) 34 (56.7) 84 (71.2) 63 (87.5) 0.000 54 (53.5) 127 (85.2) 0.000
Dyslipidemia, n (%) 40 (66.7) 88 (74.6) 62 (86.1) 0.030 72 (71.3) 118 (79.2) 0.151
Hyperglycemia, n (%) 13 (21.7) 26 (22) 22 (30.6) 0.353 23 (22.8) 38 (25.5) 0.622
Smoking, n (%) 37 (61.7) 54 (45.8) 38 (52.8) 0.130 57 (56.4) 72 (48.3) 0.208
Family history, n (%) 19 (31.7) 55 (46.6) 33 (45.8) 0.135 44 (43.6) 63 (42.3) 0.841
Previous MI, n (%) 5 (8.3) 10 (8.5) 7 (9.7) 0.948 10 (9.9) 12 (8.1) 0.613
Previous PCI, n (%) 5 (8.3) 11 (9.3) 7 (9.7) 0.961 11 (10.9) 12 (8.1) 0.442
Previous CABG, n (%) 0 (0) 0 (0) 1 (1.4) - 0 (0) 1 (0.7) -
BMI = body mass index; CABG = coronary artery bypass graft; MI = myocardial infarction; PCI = percutaneous coronary intervention; 
WC = waist circumference
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Angina pectoris, n (%) 60 (100) 114 (96.6) 71 (98.6) 0.283 99 (98) 146 (98) 0.985
Dyspnea, n (%) 25 (41.7) 27 (22.9) 23 (31.9) 0.032 27 (26.7) 48 (32.2) 0.353




Arrhythmias, n (%) 11 (18.3) 20 (17) 12 (16.7) 0.964 14 (13.9) 29 (19.5) 0.250
Conduction abnorm., 
n (%) 6 (10) 6 (5.1) 4 (5.6) 0.422 4 (4) 12 (8.1) 0.194
Heart failure, n (%) 17 (28.3) 25 (21.2) 22 (30.6) 0.306 20 (19.8) 44 (29.5) 0.084
Cardiogenic shock, n (%) 6 (10) 8 (6.8) 4 (5.6) 0.598 7 (6.9) 11 (7.4) 0.892
Cardiac arrest, n (%) 9 (15) 16 (13.6) 11 (15.3) 0.937 12 (11.9) 24 (16.1) 0.350
Mechanical ventilation, 
n (%) 2 (3.3) 5 (4.2) 3 (4.2) 0.955 2 (2) 8 (5.4) 0.180
Reinfarction, n (%) 0 (0) 1 (0.8) 0 (0) - 0 (0) 1 (0.7) -
Re-PCI, n (%) 1 (1.7) 3 (2.5) 0 (0) - 1 (1) 3 (2) -
Mortality, n (%) 6 (10) 6 (5.1) 7 (9.7) 0.365 10 (9.9) 9 (8.3) 0.258
Total, n (%) 27 (45) 45 (38.1) 32 (44.4) 0.575 36 (35.6) 68 (45.6) 0.116
Labora-
tory
Max. cTnT (ng/mL) 3.7 (0-10) 3 (0-10) 2.9 (0-10) 0.642 3.5 (0-10) 2.8 (0-10) 0.246









ECHO Left ventricle ejection 




Stenosed CAs 2 (1-4) 2 (1-4) 1 (1-3) 0.456 1 (1-4) 2 (1-4) 0.399
≥2 stenosed CAs, n (%) 33 (55) 60 (50.8) 35 (48.6) 0.761 48 (47.5) 80 (53.7) 0.339
Number of stents 1 (1-4) 1 (1-3) 1 (1-3) 0.266 1 (1-4) 1 (1-3) 0.269
Stents diameter (mm) 3 (2.5-4) 3.5 (2.3-4) 3.5 (2.8-4) 0.000 3 (2.8-4) 3.5 (2.3-4) 0.184
Stents length (mm) 18 (8-36) 20 (8-38) 20 (8-38) 0.099 18.5 (8-38) 20 (8-38) 0.060
Proximal/middle CA 
segment stenosis, n (%) 54 (90) 106 (90.6) 66 (91.7) 0.944 88 (88) 138 (92.6) 0.217
Distal CA segment 
stenosis, n (%) 27 (45) 47 (40.2) 23 (31.9) 0.289 38 (39.2) 59 (39.6) 0.800
MACE Reinfarction, n (%) 1 (1.9) 0 (0) 1 (1.5) - 1 (1.1) 1 (0.7) -
Restenosis, n (%) 2 (3.8) 4 (3.8) 1 (1.5) 0.655 4 (4.4) 3 (2.2) 0.349
New stenosis, n (%) 1 (1.9) 3 (2.8) 3 (4.4) 0.712 4 (4.4) 3 (2.1) 0.349
Cardiac rehosp., n (%) 8 (15.1) 18 (17) 11 (16.2) 0.954 13 (14.3) 24 (17.6) 0.502
Non-cardiac rehosp., 
n (%) 5 (9.4) 3 (2.8) 1 (1.5) 0.059 4 (4.4) 5 (3.7) 0.786
CVI, n (%) 1 (1.9) 0 (0) 0 (0) - 0 (0) 1 (0.7) -
Urgent CABG, n (%) 1 (1.9) 3 (2.8) 2 (2.9) 0.925 1 (1.1) 5 (3.7) 0.236
Mortality, n (%) 3 (5.7) 1 (0.9) 0 (0) - 2 (2.2) 2 (1.5) -
Total, n (%) 11 (20.8) 20 (18.4) 16 (23.5) 0.706 18 (19.8) 29 (20.9) 0.842
Other Sick leave duration 
(weeks) 12 (2-52) 12 (1-28) 14 (2-48) 0.401 12 (1-48) 12 (3-52) 0.093
BMI = body mass index; CABG = coronary artery bypass graft; CA = coronary artery; CK = creatinine phosphokinase; cTnT = cardiac 
troponin T; CVI = cerebrovascular insult; ECHO = echocardiography; MACE = major adverse cardiovascular events; PCI = percutaneous 
coronary intervention; WC = waist circumference
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nosed coronary arteries increased the risk of total 
MACE, which is consistent with literature data12.
Several studies have reported a paradoxical clinical 
eff ect of elevated BMI on improved survival after pri-
mary PCI in patients with acute STEMI, i.e. the over-
all ‘obesity paradox’. Overweight and obese patients 
had wider stents, normal LVEF, lower CK levels, in-
hospital and overall mortalities, as well as lower rates 
of MACE during 12-month follow up13-16.
According to other authors, obese patients with 
acute STEMI had similar PCI characteristics and 
MACE as normal weights and overweights17. Iako-
bishvili et al. and Li et al. found no signifi cant diff er-
ences in infarct size, and in 3-month and 1-year out-
comes among the BMI categories with acute STEMI 
and primary PCI18,19.
Th e ‘obesity paradox’ could explain why we found 
no signifi cant diff erences among normal weight, over-
weight and overall obese patients in prognosis, as well 
as that of the severity parameters, normal weight in-
creased and overweight reduced the risk of dyspnea.
Th e presence of increased WC is associated with 
greater myocardial necrosis in patients with acute 
MI20. However, it has been reported that increased 
WC has a protective role for the presence of signifi -
cant angiographic CAD, i.e. central ‘obesity paradox’21. 
Subcutaneous fat component is probably mainly re-
sponsible for the paradoxical protective eff ect of cen-
tral obesity, whereas visceral fat may have an opposing 
eff ect and increase the risk of signifi cant angiographic 
CAD. WC does not add prognostic information for 
predicting six-month mortality or myocardial reinfarc-
tion in patients with acute MI22. In this study, we found 
no signifi cant diff erences in any of the parameters of 
severity and prognosis between patients with normal 
and increased WC.
Th e presence of increased WHR is associated with 
signifi cant coronary stenosis, but not with the number 
of signifi cantly stenosed coronary arteries23. In acute 
STEMI, patients with increased WHR more fre-
quently have heart failure and WHR ≥0.90/0.85 is an 
independent predictor of six-month mortality24. In our 
study, where a small number of patients with normal 
WHR was found as expected, the presence of in-
creased WHR was associated with signifi cant stenosis 
of proximal/middle coronary segments, but without 
signifi cant diff erences in other severity and in all prog-
nostic parameters.
Of the anthropometric parameters, WHtR yielded 
the highest positive correlation with CAD25. Th is was 
the fi rst study on the eff ect of WHtR on clinical sever-
ity and prognosis of acute STEMI. We found that 
WHtR ≥63/58 increased the risk of heart failure and 
total in-hospital complications. Considering the small 




















Men, n (%) 36 (85.7) 105 (82.7) 36 (44.4) <0.0001 8 (28.6) 169 (76.1) 0.000
Women, n (%) 6 (14.3) 22 (17.3) 45 (55.6) <0.0001 20 (71.4) 53 (23.9) 0.000
Age (years) 60 (42-86) 60 (25-92) 64 (39-85) 0.162 70 (39-88) 61 (25-92) 0.021
Arterial hypertension, n (%) 24 (57.1) 84 (66.1) 73 (90.1) <0.0001 21 (75) 160 (72.1) 0.744
Dyslipidemia, n (%) 33 (78.6) 97 (76.4) 60 (74.1) 0.849 17 (60.7) 173 (77.9) 0.044
Hyperglycemia, n (%) 8 (19.0) 29 (22.8) 24 (29.6) 0.364 6 (21.4) 55 (24.8) 0.698
Smoking, n (%) 27 (64.3) 62 (48.8) 40 (49.4) 0.196 11 (39.3) 118 (53.2) 0.166
Family history, n (%) 19 (45.2) 52 (40.9) 36 (44.4) 0.831 12 (42.9) 95 (42.8) 0.995
Previous MI, n (%) 5 (11.9) 11 (8.7) 6 (7.4) 0.704 3 (10.7) 19 (8.6) 0.704
Previous PCI, n (%) 6 (14.3) 13 (10.2) 4 (4.9) 0.199 2 (7.1) 21 (9.5) 0.689
Previous CABG, n (%) 0 (0) 1 (0.8) 0 (0) - 0 (0) 1 (0.5) -
CABG = coronary artery bypass graft; MI = myocardial infarction; PCI = percutaneous coronary intervention; WHR = waist-to-hip ratio; 
WHtR = waist-to-height ratio
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Angina pectoris, n (%) 41 (97.6) 124 (97.6) 80 (98.8) 0.836 27 (96.4) 218 (98.2) 0.529
Dyspnea, n (%) 15 (35.7) 36 (28.3) 24 (29.6) 0.662 10 (35.7) 65 (29.3) 0.484




Arrhythmias, n (%) 5 (11.9) 23 (18.1) 15 (18.5) 0.607 2 (7.1) 41 (18.5) 0.135
Conduction abnorm., 
n (%) 2 (4.8) 10 (7.9) 4 (4.9) 0.626 3 (10.7) 13 (5.9) 0.322
Heart failure, n (%) 9 (21.4) 26 (20.5) 29 (35.8) 0.038 9 (32.1) 55 (24.8) 0.400
Cardiogenic shock, n (%) 4 (9.5) 7 (5.5) 7 (8.6) 0.567 1 (3.6) 17 (7.7) 0.431
Cardiac arrest, n (%) 5 (11.9) 17 (13.4) 14 (17.3) 0.649 2 (7.1) 34 (15.3) 0.246
Mechanical vent., n (%) 1 (2.4) 4 (3.1) 5 (6.2) 0.467 0 (0) 10 (4.5) 0.252
Reinfarction, n (%) 0 (0) 0 (0) 1 (1.2) - 0 (0) 1 (0.5) -
Re-PCI, n (%) 0 (0) 4 (3.1) 0 (0) - 0 (0) 4 (1.8) -
Mortality, n (%) 5 (11.9) 9 (7.1) 5 (6.2) 0.499 2 (7.1) 17 (7.7) 0.923
Total, n (%) 12 (28.6) 49 (38.6) 43 (53.1) 0.020 10 (35.7) 94 (42.3) 0.503
Labora-
tory
Max. cTnT (ng/mL) 3.7 (0.1-10) 3.7 (0-10) 2.6 (0-10) 0.061 2.1 (0-10) 3.2 (0-10) 0.071









ECHO Left ventricle ejection 




Stenosed CAs 1.5 (1-3) 1 (1-4) 2 (1-4) 0.740 1.5 (1-4) 2 (1-4) 0.750
≥2 stenosed CAs, n (%) 21 (50.0) 62 (48.8) 45 (55.6) 0.629 14 (50) 114 (51.4) 0.893
Number of stents 1 (1-3) 1 (1-4) 1 (1-3) 0.432 1 (1-3) 1 (1-4) 0.119
Stents diameter (mm) 3 (2.8-4.0) 3.5 (2.5-4.0)
3.5 
(2.3-4.0) 0.062 3 (2.8-4) 3.5 (2.3-4) 0.515
Stents length (mm) 20 (8-36) 20 (12-38) 20 (12-36) 0.291 20 (8-36) 20 (8-38) 0.905
Proximal/middle CA 
segment stenosis, n (%) 37 (88.1) 113 (89.7) 76 (93.8) 0.487 21 (75) 205 (92.8) 0.002
Distal CA segment 
stenosis, n (%) 15 (35.7) 51 (40.5) 31 (38.3) 0.850 15 (53.6) 82 (37.1) 0.092
MACE Reinfarction, n (%) 0 (0) 1 (0.9) 1 (1.3) - 0 (0) 2 (1) -
Restenosis, n (%) 2 (5.4) 5 (4.3) 0 (0) - 1 (3.7) 6 (3) -
New stenosis, n (%) 2 (5.4) 3 (2.6) 2 (2.6) 0.659 2 (7.4) 5 (2.5) -
Cardiac rehosp., n (%) 3 (8.1) 22 (18.8) 12 (15.8) 0.303 2 (7.4) 35 (17.5) 0.183
Non-cardiac rehosp., 
n (%) 1 (2.7) 6 (5.1) 2 (2.6) 0.626 1 (3.7) 8 (4) 0.941
CVI, n (%) 0 (0) 1 (0.9) 0 (0) - 0 (0) 1 (0.5) -
Urgent CABG, n (%) 0 (0) 4 (3.4) 2 (2.6) - 0 (0) 6 (3) -
Mortality, n (%) 0 (0) 3 (2.6) 1 (1.3) - 0 (0) 4 (2) -
Total, n (%) 5 (13.5) 28 (23.9) 14 (18.4) 0.340 7 (25.9) 40 (19.7) 0.451
Other Sick leave duration 
(weeks) 16 (2-24) 12 (1-52) 12 (3-40) 0.118 12 (10-26) 12 (1-52) 0.656
CABG = coronary artery bypass graft; CA = coronary artery; CK = creatinine phosphokinase; cTnT = cardiac troponin T; CVI = cerebro-
vascular insult; ECHO = echocardiography; MACE = major adverse cardiovascular events; PCI = percutaneous coronary intervention; 
WHR = waist-to-hip ratio; WHtR = waist-to-height ratio
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number of patients with normal WHR and WHtR 
values as the main limitation of this study, investiga-
tion with a greater number of patients should be per-
formed to confi rm these results.
Conclusion
In conclusion, WHR and WHtR are better an-
thropometric parameters than BMI in predicting 
acute STEMI severity, while WC has no infl uence on 
it. Anthropometry has no infl uence on prognosis.
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Sažetak
ULOGA ANTROPOMETRIJE U AKUTNOM INFARKTU MIOKARDA SA ST-ELEVACIJOM 
LIJEČENOM PRIMARNOM PERKUTANOM KORONARNOM INTERVENCIJOM
M. Mornar Jelavić, Z. Babić, H. Pintarić i M. Mišigoj-Duraković
Cilj ove studije bio je istražiti proturječni utjecaj antropometrije na kliničku težinu i prognozu akutnoga infarkta mio-
karda sa ST-elevacijom (STEMI). Prospektivno smo analizirali 250 bolesnika s akutnim STEMI liječenih primarnom per-
kutanom koronarnom intervencijom (rujan 2011. – rujan 2012.). Oni su grupirani prema antropometrijskim parametrima: 
indeks tjelesne mase (BMI) (<25,0; 25,0-29,9; ≥30,0 kg/m²), opseg struka (WC) (<102/88, ≥102/88 cm), omjer struk/boko-
vi (WHR) (<0,90/0,85, ≥0,90/0,85) i struk/tjelesna visina (WHtR) (<53/49, 53/49-62/57, ≥63/58). Skupine su analizirane 
prema bazičnim te parametrima težine (klinički, laboratorijski, ehokardiografski, koronarografski, bolničke komplikacije) i 
prognoze (glavni neželjeni kardiovaskularni događaji (MACE) i duljina bolovanja (SLD) tijekom 12 mjeseci praćenja). 
 Bolesnici s BMI <25,0 kg/m2 imali su najveću učestalost dispneje, a oni s BMI ≥30,0 kg/m2 najdulju hospitalizaciju i najšire 
stentove; bolesnici s WHR ≥0,90/0,85 učestalije su imali značajno stenozirane proksimalne/srednje koronarne segmente, 
dok su oni s WHtR ≥63/58 imali najveću učestalost srčanog zatajivanja i ukupnih bolničkih komplikacija (p<0,05). BMI 
<25,0 kg/m2 povećava (odds ratio (OR) 2,00, confi dence interval (CI) [1,09-3,68], p=0,026), a BMI 25,0-29,9 kg/m2 sma njuje 
(OR 0,52, CI [0,30-0,91], p=0,022) rizik dispneje; WHR ≥0.90/0.85 povećava rizik značajne stenoze proksimalnih/srednjih 
koronarnih segmenata (OR 3,34, CI [1,13-9,86], p=0,029), a WHtR ≥63/58 srčanog zatajenja (OR 2,05, CI [1,13-3,71], 
p=0,017) i ukupnih bolničkih komplikacija (OR 1,94, CI [1,13-3,33], p=0,017) (p<0,05). Zaključno, WHR i WHtR su 
bolji antropometrijski parametri od BMI u predviđanju težine akutnog STEMI, dok WC nema utjecaja. Antropometrija 
nema utjecaja na prognozu.
Ključne riječi: Antropometrija; Pretilost; Srčani infarkt; Perkutana koronarna intervencija; Bolovanje
